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Abstract
Oral carcinogenesis often leads to the alteration of the microbiota at the site of the tumor, but data are scarce regarding the
microbial communities of oral potentially malignant disorders (OPMDs). Punch biopsies were taken from healthy and non-
healthymucosa of OPMDpatients to analyze themicrobiome usingmetagenome sequencing. In healthy oral mucosa biopsies the
bacterial phyla Firmicutes, Fusobacteria, Proteobacteria, Actinobacteria and Bacteroidetes were detected by Ion Torrent se-
quencing. The same phyla as well as the phyla Fibrobacteres and Spirochaetes were present in the OPMD biopsies. On the
species level, there were 10 bacterial species unique to the healthy tissue and 35 species unique to the OPMD lesions whereas
eight species were detected in both samples. We observed that the relative abundance of Streptococcus mitis decreased in the
OPMD lesions compared to the uninvolved tissue. In contrast, the relative abundance of Fusobacterium nucleatum, implicated in
carcinogenesis, was elevated in OPMD.We detectedmarkedly increased bacterial diversity in the OPMD lesions compared to the
healthy oral mucosa. The ratio of S. mitis and F. nucleatum are characteristically altered in the OPMD lesions compared to the
healthy mucosa.
Keywords OPMD .Oral microbiome .Metagenome sequencing . Lichen . Leukoplakia
Introduction
Numerous scientific data demonstrate the altered bacterial col-
onization of cancerous tissue, but the causality of microbial
alteration has not clarified yet.
The role of oral microbes in the development of oral poten-
tially malignant disorder (OPMD) and oral squamous cell car-
cinoma (OSCC) is periodically reevaluated, since OPMD or
OSCCmay develop in the absence of the traditional risk factors
like smoking, alcohol consumption and betel nut use [1–3].
While the microbiological background of oral squamous cell
carcinoma was intensively studied in the last two decades, less
attention has been paid to OPMD in this respect [4].
OPMD is a group of disorders of diverse etiologies, fre-
quently associated with tobacco consumption and mutations
in the DNA of oral epithelial cells. A fraction of OPMD un-
dergoes clinical and histomorphological alterations that lead
to the development of OSCC. These disorders include leuko-
plakia, erythroplakia, oral lichen planus, submucous fibrosis,
and actinic cheilitis [5, 6]. In addition, inherited cancer syn-
dromes such as xeroderma pigmentosum and Fanconi’s
* Krisztina Buzas
kr.buzas@gmail.com; buzas.krisztina@brc.mta.hu
1 Faculty of Dentistry, Department of Oral Surgery, University of
Szeged, Tisza Lajos krt. 64, Szeged H-6720, Hungary
2 Albert Szent-Gyorgyi Clinical Centre, Institute of Clinical
Microbiology, University of Szeged, Semmelweis u. 6,
Szeged H-6725, Hungary
3 Biological Research Centre, Hungarian Academy of Sciences,
Temesvari krt. 62, Szeged H-6726, Hungary
4 Albert Szent-Gyorgyi Clinical Centre, Department of Traumatology,
University of Szeged, Semmelweis u. 6, Szeged H-6725, Hungary
5 Department of Biochemistry and Molecular Biology, University of
Szeged, Kozep fasor 52, Szeged H-6726, Hungary
6 dicomLAB Ltd., Pulz u. 46/b, Szeged H-6724, Hungary
7 Faculty of Dentistry, Department of Oral Biology and Experimental
Dental Research, University of Szeged, Tisza Lajos krt. 64,
Szeged H-6720, Hungary
8 Department of Dermatology and Allergology, University of Szeged,
Szeged H-6720, Hungary
Pathology & Oncology Research
https://doi.org/10.1007/s12253-018-0457-x
anemia are also associated with an increased incidence of
malignant tumors, among them oral carcinoma [6].
Leukoplakia is defined as ″A white plaque of ques-
tionable risk having excluded (other) known diseases or
disorders that carry no increased risk for cancer″.
Leukoplakia is six times more common among smokers
than among non-smokers [6]. These lesions are divided
into homogenous (simplex) and non-homogenous types.
The non-homogenous types based on the cellular vari-
ability are verrucous leukoplakia, nodular leukoplakia
and erythroleukoplakia [7]. Proliferative verrucous leu-
koplakia (PVL) is a subtype of verrucous leukoplakia
that shows resistance to treatment and a high rate of
malignant transformation. It is more frequent among el-
derly women, in many cases without smoking in the
anamnesis. Distinct histopathological changes, like hy-
perkeratosis with or without dysplasia, may accompany
the transition of PVL to verrucous hyperplasia and
verrucous carcinoma [6].
There are conflicting results regarding the association of leu-
koplakia and human papillomavirus (HPV) infection [6, 8]. The
role of torque teno virus (TTV) [9, 10], Epstein-Barr virus (EBV)
[11] and Candida albicans [8, 12–16] in leukoplakia develop-
ment and carcinogenesis remains to be clarified, too.
Additionally, it has been also demonstrated that specific bacterial
infections like Helicobacter pylori [17] or the intracellular
Mycoplasma salivarium [18] could also be involved in this
process.
A disbalance in the oral microbial flora can be also accom-
panied with leukoplakia and carcinogenesis, as suggested by
the association of periodontal inflammation with leukoplakia
[19] and a changing bacterial flora in the saliva and on the oral
mucosal surfaces of patients with OPMD [20, 21].
Lichen planus (LP) is a chronic, idiopathic, inflammatory
disease of the oral mucosa or the skin, presenting as a white
lesion when it affects the oral cavity (oral lichen planus, OLP).
A crucial aspect of the pathomechanism of OLP is the accu-
mulation of CD8+ T lymphocytes under the basal cell layer of
the oral mucosa, which causes DNA damage and the apopto-
sis of the keratinocytes by antigen-specific cell-mediated im-
mune response, and also basement membrane degradation
[22–25]. According to the most accepted hypothesis, chronic
stimulation from the inflammatory and stromal cells provides
the initial signal which lead to the abolished growth control of
epithelial cells. Additionally, oxidative stress induced DNA
damage could also lead to neoplastic changes, but the initial
event leading to this signal cascade activation has not been
characterized yet. Based on the increasing evidence viral, fun-
gal, and bacterial antigens have all been suggested [26–34] as
a potential initiating factor in LP. If there is a relationship
between the bacterial flora and OLP, the question is whether
the trigger area is in the oral cavity, or at another area of the
body, such as the skin, the gastrointestinal tract, the larynx or
the eyes. If oral bacterial infection could initiate OLP devel-
opment, it is not clear whether a single bacterial species could
initiate the OLP transformations, or is it the interaction of
several species during the process? Additionally, the disturbed
balance of the normal bacterial flora could also be involved in
the initial steps of OLP activation.
In our experimental setup, we examined the oral
microbiome of patients diagnosed with OPMD. We compared
the microbiome of healthy and non-healthy mucosal surfaces.
Using metagenome sequencing, we detected markedly in-
creased bacterial diversity in the OPMD lesions compared to
the healthy oral mucosa. In parallel, in the OPMD lesions there
was a reduced representation of distinct Streptococcus species
that dominate the bacterial community of healthy oral mucosa.
Materials and Methods
Patient Selection
Potential participants were interviewed by the clinical coordi-
nators at the University of Szeged, Faculty of Dentistry. Every
potential participant was informed about the ethical permis-
sion of the study and received both written and oral informa-
tion on the goals and procedures of this study. The initial
participants were selected by volunteering activity and the
detailed questionnaire on family anamnesis, chronic diseases,
medication-, alcohol-, tobacco- and drug consumption, oral
hygiene, and sexual habits was filled out by the volunteers.
Eligibility was determined based on the results of this ques-
tionnaire. Female and male subjects over 18 years of age were
eligible for the study, provided that they were able to provide
signed and dated informed consent and if they did not meet
any of the exclusion criteria. As for the patient group, an
established diagnosis of OPMD was also a requirement. The
exclusion criteria included vital signs outside the acceptable
range at the screening visit (i.e., blood pressure > 140/
90 mmHg, oral temperature > 37 °C, heart rate > 100/
min), pregnancy, the potential subject being a sex work-
er, topical antibiotic treatment up to 7 days before the
screening visit, and the use of the following drugs with-
in 2 months before the screening visit: systemic antibi-
otics, corticosteroids, cytokines, methotrexate or immu-
nosuppressive cytotoxic agents, or large doses of com-
mercial probiotics (≥ 108 CFU mL−1 organisms per
day). No patients were on specific diet, nor on antibi-
otic therapy in the previous 6 months. The clinical char-
acteristics and brief medical history of the patient group
is given in Table 1.
The study protocol conformed to the Declaration of
Helsinki in all respects and was approved by the Institutional
Ethics Committee of the University of Szeged (No. 3161).
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Tissue Sample Collection for Metagenome
Sequencing, Histopathological Assessment
As a classical method for tissue sample collection from muco-
sal lesions in the oral cavity, we used punch biopsy. The biopsy
was made with punches 4 mm in diameter. We collected 2
identical samples from the intralesional area: one sample was
taken for hematoxylin-eosin (HE) staining, and an additional
sample for metagenome sequencing. Additionally, we also col-
lected a third, control specimen from the ipsilateral healthy
mucosa for metagenome sequencing. The specimens contained
the mucosa, and submucosal connective tissue. Samples for
metagenome sequencing were collected in Eppendorf tubes
filled with 20 mM potassium phosphate buffer (pH 7.0), and
stored at −20 °C. Tissue samples for HE staining were fixed in
formaldehyde solution, and sent for histopathological assess-
ment. Pathological dataset (Table 2) included the absence or
presence, together with severity of hyperkeratosis, hyperplasia,
reactive atypia, dysplasia, and lichenoid infiltrate [35].
Metagenomic DNA Isolation
Total DNA was isolated from patient samples as de-
scribed previously, with minor modifications [36].
Briefly, samples (600 μL) were suspended in 650 μL
of extraction buffer (100 mM TrisCl, pH 8.0, 100 mM
EDTA, pH 8.0, 1.5 M NaCl, 100 mM sodium phos-
phate, pH 8.0, 1% CTAB) 3.5 μL proteinase K
(20.2 mg mL−1) and incubated horizontally at 37 °C
for 45 min, next 80 μL of 20% SDS was added and
mixed by inversion for several times with further incu-
bation at 60 °C for 1 h. The sample in each tube was
mixed thoroughly every 15 min. The particles were col-
lected by centrifugation (17,000 g) for 5 min. The su-
pernatant was transferred into clean tubes and was
mixed with equal quantity of phenol chloroform and
isoamyl alcohol (25:24:1) and extracted three times.
DNA was precipitated with 0.7 volume isopropanol,
the pellet was washed with 70% ethanol. Crude DNA
pellets were dried and dissolved in 50 μL of TE buffer
(10 mM Tris-HCl, 1 mM sodium EDTA, pH 8.0).
Metagenomic DNA was quantified using Qubit® 2.0
Fluorometer. Half of total metagenomic DNA from the
Table 2 The histopathological characteristics of the biopsies
patient # 1 2 3 4 5 6 7
OPMD + + + + + + +
hyperkeratosis + ++ +++ +++ + +++ +++
hyperplasia +++ ++ + +++ – +++ +++
reactive atypia – + – + – + +
dysplasia – + – – – – –
lichenoid infiltrate + +++ ++ +++ +++ +++ ++
MT – – – – – – –
Abbreviations: (− no, + mild, ++ moderate, +++ severe; OPMD: oral
potentially malignant disorder; MT: malignant transformation)
Fig. 1 Representative pictures from OPMD tissue samples OPMD
tissue samples with marked hyperkeratosis (a, b – HyKer), acanthosis
and lichenoid infiltrate (a, d – LI). Occasionally there was a marked
verrucous hyperplasia with elongated dermal papillae (c – DP). Note
the regenerative basal cell changes (b – RA/regenerative atypia/), in
contrast to mild dysplasia (d – DY) with focal acantholysis /HE; OM
112×/
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healthy and lesion samples were pooled and stored at
−20 °C for sequencing.
Library Preparation and Sequencing
Ion Torrent PGM Fragment libraries of 200 nt were generated
according to the appropriate protocols (Ion Torrent PGM, Life
Tech, USA). 1 μg pooled metagenomic DNA from each sam-
ple was used for library preparation for each sample. DNA
shearing and end-repair was achieved by Ion Xpress™ Plus
Fragment Library Kit, and DNA Purification was carried out
by PureLink PCR Purification Kit (Thermo Fisher Scientific,
MA). Adapter ligation and nick translation were performed by
Ion Shear Plus Reagents Kit (Thermo Fisher Scientific, MA).
Size selection was performed in 2% agarose gel to enrich the
300–350 nt fragments then library amplification was achieved
by using Platinum® PCR SuperMix (Thermo Fisher Scientific,
MA). ION Library TaqMan qPCR was used for quantitation
and Ion Xpress Template 200 ePCR kit was used for the emul-
sion PCR. Sequencing was performed on Ion Torrent Personal
Genome Machine™ using Ion 318 chip. Ion Torrent Personal
Genome Machine™ sequencing resulted 872,798 sequence
reads for sample 1 (control) with an average read length of
219 ± 71 bases and 644,200 sequence reads for sample 2
(diseased) with an average read length of 220 ± 72 bases.
Quality Assurance
The MG-RAST software performs a QC (quality control) and
an automatic normalization of the FASTQ sequence. For the
taxonomical analyses, maximum e-value cut-off of 10−15,
minimum percent identity cut-off 90% and minimum align-
ment length cut-off 40 nt settings were applied. The overall
community composition was determined using the M5nr da-
tabase. Hits for the eukaryotic data were removed and relative
abundance of the bacterial data was calculated.
Swab Sample Collection
We used cotton swabs for collecting bacterial samples. Two
individual samples were taken from each patient, one from
the surface of the lesion, and another one from the ipsilateral
healthy (non-involved) mucosa. The swabs were rolled 4 times
over the chosen areas. Then the swabs were placed in anaerobic
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Fig. 2 Distribution of
taxonomic domains Significant
differences were not found in the
distributions of taxonomic
domains between the healthy
tissue and the OPMD lesion.
6.78% of bacterial domains were
detected in healthy area compared
6.87% of bacterial domains in
white lesions of oral mucosa
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Fig. 3 Bacterial diversity a
Metagenome sequencing revealed
that the bacterial diversity in the
OPMD biopsies was higher
compared to the healthy oral
mucosa. Within the Bacteria
domain Firmicutes,
Fusobacteria, Proteobacteria,
Actinobacteria, Bacteroidetes
phyla were present in the healthy
oral mucosa. In the OPMD
biopsies the same phyla were
identified in descending order of
relative abundance; however, two
additional phyla, Fibrobacteres
and Spirochaetes were observed,
too. b Metagenome sequencing
detected 18 different bacterial
species in healthy tissue and 43
species in the OPMD lesion.
Eight bacterial species were
detected in both samples
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transport medium (AnaerobeSystems, CA) and sent immedi-
ately to the Institute of Clinical Microbiology, University of
Szeged, for Fusobacterium nucleatum cultivation.
Fusobacterium nucleatum qPCR
DNA templates for qPCR were prepared from the undiluted
BHI suspensions of the oral swabs by the QiAmp Stool Mini
DNA Kit (Qiagen, Germany) as recommended by the supplier.
Subsequent quantitative RT-PCRs for Fusobacterium
nucleatum were done in StepOne RT-PCR instrument
(Invitrogen, CA) using 5 μL Brilliant II master mix (Agilent),
primers FnucF CTTAGGAATGAGACAGAGATG and FnucR
TGATGGTAACATACGAAAGG 0.2 μL (35 pmole/μL) each,
1 μL of template sample and the following cycling conditions:
starting denaturation and hot start activation 95 °C 10 min,
95 °C 15 s, 56 °C 15 s and 72 °C 30 s, 40×; and a melting curve
from 72 °C to 95 °C [37] CFUs were calculated comparing the
means of threshold cycles to ones of a F. nucleatum 10-fold
serial dilution samples prepared with the same kit.
Data Analysis
For the comparison of the numerical data, the Mann-Whitney
U test was used in SPSS 21.0 (IBM, NY).
Results
Sample selectionwas based on the histological analysis of oral
potentially malignant disorder. Figure 1 shows representative
pictures of the OPMD tissue samples with marked hyperker-
atosis, acanthosis and lichenoid infiltration. Table 1. describes
the brief medical history of selected patients (Selection criteria
has been found in Materials and methods). Detailed histolog-
ical classification summarized in Table 2.
OPMDHealthy
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Fig. 4 Comparison of the detected bacterial speciesMetagenome sequencing detected 18 different bacterial species in healthy tissue and 43 species in
the OPMD lesion
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First, we determined the ratio of bacterial DNA in our
sample. As punch biopsy samples contain a high amount of
human tissue, this step helped us to define the limitation of the
study. In healthy oral mucosa samples, 6.78% of the sequence
reads were annotated to the domain Bacteria. The ratio of
bacterial sequences was similar (6.87%) in the pooled
OPMD DNA samples (Fig. 2).
Metagenome sequencing revealed that the bacterial
diversity in the OPMD biopsies was higher compared
to the healthy oral mucosa. Within the Bacteria domain
F i rm i c u t e s , F u s o b a c t e r i a , P ro t e o b a c t e r i a ,
Actinobacteria, Bacteroidetes phyla were present in the
healthy oral mucosa. In the OPMD biopsies the same
phyla, i.e. Firmicutes, Fusobacteria, Proteobacteria,
Actinobacteria and Bacteroidetes were identified in de-
scending order of relative abundance; however, two ad-
ditional phyla, Fibrobacteres and Spirochaetes were ob-
served, too (Fig. 3a).
Table 3 Comparison of bacterial diversity in the healthy mucosa and the OPMD lesion
Species Phylum Healthy OPMD
Streptococcus mitis Firmicutes 32,73% 18,62%
Streptococcus pneumoniae Firmicutes 25,45% 13,79%
Gemella haemolysans Firmicutes 7,27% 1,38%
Rothia dentocariosa Actinobacteria 3,64% 0,021
Fusobacterium nucleatum Fusobacteria 3,64% 5,52%
Actinomyces urogenitalis Actinobacteria 1,82% 0,69%
Streptococcus oralis Firmicutes 1,82% 4,14%
Haemophilus influenzae Proteobacteria 1,82% 1,38%
Fusobacterium sp. 3_1_36A2 Fusobacteria 3,64% 0
Fusobacterium sp. 4_1_13 Fusobacteria 3,64% 0
Porphyromonas gingivalis Bacteroidetes 1,82% 0
Prevotella bergensis Bacteroidetes 1,82% 0
Gemella morbillorum Firmicutes 1,82% 0
Streptococcus infantis Firmicutes 1,82% 0
Neisseria meningitidis Proteobacteria 1,82% 0
Neisseria subflava Proteobacteria 1,82% 0
Enhydrobacter aerosaccus Proteobacteria 1,82% 0
Psychrobacter sp. PRwf-1 Proteobacteria 1,82% 0
Streptococcus parasanguinis Firmicutes 0 4,83%
Fibrobacter succinogenes Fibrobacteres 0 4,14%
Streptococcus sp. M143 Firmicutes 0 4,14%
Campylobacter concisus Proteobacteria 0 4,14%
Streptococcus sanguinis Firmicutes 0 2,76%
Streptococcus sp. M334 Firmicutes 0 2,76%
Prevotella melaninogenica Bacteroidetes 0 2,07%
Capnocytophaga ochracea Bacteroidetes 0 2,07%
Streptococcus vestibularis Firmicutes 0 2,07%
Veillonella parvula Firmicutes 0 2,07%
Rothia mucilaginosa Actinobacteria 0 2,07%
Corynebacterium efficiens Actinobacteria 0 1,38%
Corynebacterium matruchotii Actinobacteria 0 1,38%
Granulicatella adiacens Firmicutes 0 1,38%
Streptococcus gordonii Firmicutes 0 1,38%
Streptococcus salivarius Firmicutes 0 1,38%
Leptotrichia buccalis Fusobacteria 0 1,38%
Actinomyces sp. oral taxon 171 Actinobacteria 0 0,69%
Thermomonospora curvata Actinobacteria 0 0,69%
Capnocytophaga gingivalis Bacteroidetes 0 0,69%
Gemella morbillorum Firmicutes 0 0,69%
Streptococcus pyogenes Firmicutes 0 0,69%
Streptococcus sp. C300 Firmicutes 0 0,69%
Streptococcus sp. oral taxon 071 Firmicutes 0 0,69%
Streptococcus thermophilus Firmicutes 0 0,69%
Parvimonas micra Firmicutes 0 0,69%
Eubacterium saburreum Firmicutes 0 0,69%
Veillonella sp. 3_1_44 Firmicutes 0 0,69%
Veillonella sp. oral taxon 158 Firmicutes 0 0,69%
Fusobacterium sp. 1_1_41FAA Fusobacteria 0 0,69%
Fusobacterium sp. 3_1_27 Fusobacteria 0 0,69%
Fusobacterium sp. 7_1 Fusobacteria 0 0,69%
Lautropia mirabilis Proteobacteria 0 0,69%
Delftia acidovorans Proteobacteria 0 0,69%
Simonsiella muelleri Bacteroidetes 0 0,69%
Treponema vincentii Spirochaetes 0 0,69%
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On the species level, 18 bacterial species were detect-
ed in the healthy tissue, 35 species were unique for the
OPMD lesions and eight bacterial species were detected
both in healthy oral mucosa and the OPMD biopsy
samples (Fig. 3b). Metagenome sequencing showed
markedly increased bacterial diversity in the OPMD tis-
sue samples. Analysis of bacterial species detected 2.38
fold increasing in diversity of the OPMD lesions
(Fig. 4, Table 3).
Based on the data of metagenome sequencing, the
relative abundance of Streptococcus sp. did not show
significant difference between the healthy tissue and
the OPMD lesions: it was 61.82% in healthy tissue
and 58.62% in OPMD, respectively (Fig. 5a) However,
the relative abundance of the Streptococcus mitis was
found to be dramatically decreased in OPMD: it was
only 18.62%, compared to 32.73% in the healthy tissue
(Fig. 5b). Moreover, examining all Streptococcus species
their prevalence in the OPMD lesions was determined to
be more diverse compared to the healthy tissue (Table
3).
According to the results of metagenome sequencing, the
ratio of Fusobacterium nucleatum was higher in the OPMD
lesions (5.52%), compared to the healthy tissue (3.64%)
(Fig. 6). Relative abundance of Fusobacterium nucleatum
(5.52%) and Streptococcus oralis (4.14%) bacteria were
identified in a larger portion among the overlapping bacte-
ria in OPMD while 3.64 and 1.82% were observed in
healthy tissue, respectively). The abundances of the species
Gemella haemolysans (1.38%), and the above mentioned S.
mitis (18.62%) decreased markedly in OPMD as compared
to the healthy tissue (7.27% and 32.73%) (Table 3).
35 different bacterial species has been found in the
OPMD lesions which has not been presented in the
healthy tissue, e.g., Streptococcus parasanguinis,
Fibrobacter succinogenes, Campylobacter concisus,
Streptococcus sanguinis , Rothia muci laginosa,
Prevotella melaninogenica, Capnocytophaga ochracea,
Streptococcus vest ibularis , Veil lonella parvula,
Corynebac t e r i um e f f i c i e n s , Corynebac t e r i um
matruchotii, Granulicatella adiacens, Streptococcus
gordonii, Streptococcus salivarius, Leptotrichia buccalis,
Thermomonospora curvata, Capnocytophaga gingivalis,
Streptococcus pyogenes Streptococcus thermophiles,
Parvimonas micra, Eubacterium saburreum, Lautropia
mirabilis, Delftia acidovorans, Simonsiella muelleri,
Treponema vincentii, etc., in descending order of the
abundances.
As F. nucleatum was implicated in carcinogenesis in
several cancers [38], we verified the results of
metagenome sequencing by F. nucleatum-specific
qPCR. As Fig. 7 shows, the number of bacteria
(CFUs) is significantly higher (P < 0.0001) in samples
taken from OPMD lesions than in those from the
healthy mucosa. This difference is remarkable, even
when one considers the high inter-individual variability
of the samples.
Discussion
It was suggested that OPMD was frequently associated
with alcohol and tobacco consumption, and affected
mainly males in their fifties, but the practice shows that
18.62%
81.38%
Streptococcus mitis
Other bacteria
32.73%
67.27%
Streptococcus mitis
Other bacteria
b
Healthy OPMD
58.62%
41.38%
Streptococcus sp.
Other bacteria61.82%
38.18% Streptococcus sp.
Other bacteria
a
Healthy OPMD
Fig. 5 Ratio of Streptococci in
the mucosal lesion a The ratio of
Streptococci to all oral bacteria
was not significantly different in
the healthy tissue compared to the
OPMD lesion. b The ratio of
Streptococcus mitis dramatically
decreased in the OPMD, as
compared to the healthy tissue
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a much wider variety of patients are affected [1, 3].
Accordingly, we included a wide range of patients in
our sample, without strict limitations on age or sex.
In our study we compared the microbiome and microbiota
of healthy and the OPMD tissues of oral cavity.
The association of Fusobacterium nucleatum with
oral carcinoma was documented [38, 39]. Moreover, it
was suggested that distinct subspecies of F. nucleatum,
such as F. nucleatum subsp. polymorphum and F.
n u c l e a t u m s u b s p . v i n c e n t i i , m a y p l a y a n
etiopathogenetic role in oral carcinogenesis [40]. A
study also described the presence of F. nucleatum in
desquamative gingivitis [41]. However, our report shows
the first time the presence of Fusobacterium nucleatum
in lesion biopsies of OPMD patients.
The finding that F. nucleatum is present in OPMD
may be exploited to develop a novel therapeutic strategy
of distinct oral disorders such as oral lichen planus. In
addition, one may speculate that a targeted antibiotic
therapy could be beneficial in preventing the develop-
ment of oral cancer in a subset of OPMD patients.
We observed that the relat ive abundance of
Streptococcus mitis decreased dramatically in the patho-
logical niche. Since Streptococci are characteristic com-
ponents of the oral flora, the quantitative analysis of
these bacteria is indispensable for the understanding of
pathological processes. Streptococci comprise of a wide
variety of bacterial species that interact with other mem-
bers of the oral microbiome. It was suggested that S.
mitis is involved in the maintenance of a healthy oral
flora by affecting adhesion and biofilm formation by
periodontal pathogens to [42–44].
Therefore, it is an interesting and important finding
that the relative abundance of S. mitis in the OPMD
lesions decreased to nearly the half of the healthy area.
This observation may possibly be exploited for thera-
peutic purposes: similarly to the reconditioning of vag-
inal Lactobacillus balance [45], the restitution of S.
mitis niche in OPMD could also have beneficial effects
[46].
Taken together, we presented evidence for the alter-
ation of microbiome and microbiota of OPMD patients.
We detected an increased bacterial diversity in the
OPMD lesions compared to the healthy oral mucosa.
In addition, decreased relative abundance of S. mitis
and an increased relative abundance of F. nucleatum
may play a role in the transition of OPMDs to oral
cancer.
Although our study is not suitable to answer the
BChicken or the Egg^ problem in all aspects, but we
have found that the bacterial colonization of mucosa
has already altered in OPMD tissues. These observa-
tions may form the basis of novel therapeutic ap-
proaches preventing oral carcinogenesis in a subset of
patients with OPMD.
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